Finasteride treatment for one year in 35 hirsute patients

Bayram F., Muderris I. I., Sahin Y., Kelestimur F.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, cilt.107, sa.3, ss.195-197, 1999 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 107 Sayı: 3
  • Basım Tarihi: 1999
  • Doi Numarası: 10.1055/s-0029-1212097
  • Dergi Adı: EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.195-197
  • Anahtar Kelimeler: finasteride, hirsutism, 5-ALPHA-REDUCTASE INHIBITOR FINASTERIDE, IDIOPATHIC HIRSUTISM, WOMEN, SPIRONOLACTONE, FLUTAMIDE
  • Erciyes Üniversitesi Adresli: Evet

Özet

This study was performed to confirm the favourable therapeutic effects of finasteride in hirsute women as described by previous publications of different research groups. Our study was a non-randomized, prospective clinical trial. Thirty five patients with hirsutism were included in the study. The patients received 5 mg finasteride orally once per day over a period of 12 months. Hirsutism score, FSH, LH, E-2, total T, free T, androstenedione (A), DHEAS, 17-hydroxyprogesterone (17-OHP) and sex hormone-binding globulin (SHBG) levels were determined in all the patients before treatment and every 6 months during treatment.